The Mount Sinai Health System received the first Outstanding Employer Award from STRIVE (Support Training Results In Valuable Employees) on Tuesday, January 20, at the New York Yale Club, for its exceptional commitment to training and hiring graduates from the STRIVE program. The organization presents the award to employers who help individuals with high barriers to employment—such as recovering addicts, public assistance recipients, and the working poor—develop marketable skills and gain employment in living-wage jobs. Read more
Kristjan T. Ragnarsson, MD, the Dr. Lucy G. Moses Professor and Chair of the Department of Rehabilitation Medicine for the Mount Sinai Health System, was recently honored by the American Academy of Physical Medicine and Rehabilitation with its 2014 Frank H. Krusen, MD, Lifetime Achievement Award, its highest honor. The Academy saluted Dr. Ragnarsson’s longtime commitment to patient care, research, education, and advocacy. The award was established in 1972 for Dr. Krusen, a founding father of the Academy and early developer of the Physical Medicine and Rehabilitation specialty. Read more
Researchers at the Icahn School of Medicine at Mount Sinai have identified 53 drugs approved for use in treating depression, cancer, heart disease, and other illnesses that may also be effective in fighting the Ebola virus. The findings appeared online in the December 17, 2014, journal Emerging Microbes & Infections. Read more
After completing his residency training at Icahn School of Medicine at Mount Sinai more than two decades ago, renowned surgeon Ron Shapiro, MD, has returned to the Mount Sinai Health System as Surgical Director of the Kidney and Pancreas Transplant Program at the Recanati/Miller Transplantation Institute (RMTI). Read more
Seminal research led by James Ferrara, MD, DSc, Ward-Coleman Chair in Cancer Medicine, has produced a promising approach to treating patients with graft-versus-host disease (GVHD)—a sometimes fatal complication of bone marrow transplantation in which the donor’s immune cells attack the recipient’s body. Bone marrow transplants are often used to treat patients with leukemia, lymphoma, and other blood diseases. Read more
Sean Pinney, MD, is Director of the Advanced Heart Failure and Transplantation Program at The Mount Sinai Hospital. He shared his answers to some of the most frequently asked questions of heart failure patients.
1. My health practitioner thinks I may have heart failure. Why did my health practitioner order so many different tests? Read more
The common cold is a viral infection that affects the nose and throat with associated sneezing, headaches, and cough. The rhinovirus is the most common type of virus that causes colds; however, there are more than 200 viruses that may cause the common cold. Antibiotics are not effective against viruses and are used to treat bacterial infections.
One of the largest misconceptions is that the color of the mucus suggests a bacterial infection. A patient can have yellow or green mucus and still have the common cold. The most important sign that would indicate a bacterial infection is present is the duration of symptoms. The American Academy of Otolaryngology guidelines for acute sinusitis require the presence of symptoms for greater than 7 to 10 days before being considered a bacterial infection. In addition, symptoms of the common cold may last for up to two weeks with cough and post nasal drip being the last symptoms to go away. Read more
Experts estimate that as many as 80% of people will experience back pain at some point in their lives. While the pain can be debilitating, most are able heal by themselves however, many have to turn to alternative options for treatment.
The foundation of all treatments of back pain is physical therapy yet, depending on the particular cause of back pain, there are additional treatments available. Below are five common causes of back pain and Pain Management treatments to help improve the pain. Read more
HCM causes symptoms of dyspnea or shortness of breath, chest pain, exercise intolerance, syncope or fainting, and uncommonly, sudden cardiac death (SCD). It affects individuals of all ages but most commonly presents after age 30. Many patients with HCM have a relatively benign course and can have normal life expectancy, and symptoms can be managed with first-line pharmacologic agents like beta blockers or verapamil. However, a quarter of patients will experience in their course either severe disabling symptoms or SCD. Read more
Why is HDL considered the good cholesterol, and why is it so important?
The cardioprotective effects of HDL are strongly suggested by the consistent inverse relationship between HDL levels and the risk of coronary artery disease (CAD).
When HDL is high, the risk of CAD is lessened. For example, when one eats a fatty meal, the food is broken down resulting in LDL depositing in the coronary arteries (the pipes that feed the heart). Over time, plaque builds up and the risk of heart attack increases. Read more